MDPI and ACS Style

Aon, M.; Alsaeedi, A.; Alzafiri, A.; Al-Shammari, A.; Taha, S.; Al-Shammari, O.; Tawakul, M.; Alshammari, J.; Alherz, N.; Alenezi, M.; Eyadah, M.; Aldhafeeri, M.; Alharbi, T.; Alshammari, D.; Alenezi, Z.; Aldouseri, S.; Albazee, E.; Ibrahim, M.M.; Aoun, A.H. Stress Hyperglycemia Ratio as a Prognostic Marker in Diabetic Patients Hospitalized with COVID-19. Infect. Dis. Rep. 2022, 14, 675-685. https://doi.org/10.3390/idr14050073

Aon M, Alsaeedi A, Alzafiri A, Al-Shammari A, Taha S, Al-Shammari O, Tawakul M, Alshammari J, Alherz N, Alenezi M, Eyadah M, Aldhafeeri M, Alharbi T, Alshammari D, Alenezi Z, Aldouseri S, Albazee E, Ibrahim MM, Aoun AH. Stress Hyperglycemia Ratio as a Prognostic Marker in Diabetic Patients Hospitalized with COVID-19. Infectious Disease Reports. 2022; 14(5):675-685. https://doi.org/10.3390/idr14050073

Aon, Mohamed, Abdullah Alsaeedi, Azeez Alzafiri, Abdelrahman Al-Shammari, Sherif Taha, Omar Al-Shammari, Mahmoud Tawakul, Jarrah Alshammari, Naser Alherz, Monerah Alenezi, Meshari Eyadah, Mariam Aldhafeeri, Teflah Alharbi, Duaa Alshammari, Zaid Alenezi, Salem Aldouseri, Ebraheem Albazee, Mohamed M. Ibrahim, and Ahmed H. Aoun. 2022. "Stress Hyperglycemia Ratio as a Prognostic Marker in Diabetic Patients Hospitalized with COVID-19" Infectious Disease Reports 14, no. 5: 675-685. https://doi.org/10.3390/idr14050073